ڵλã > Language Tips > Audio & Video > China Daily Audio News
China's reputation at risk
[ 2007-07-09 09:31 ]
China needs to tackle problems with food and drug quality otherwise it
risks serious damage to its credibility on the international stage, the
country's top food and drug watchdog has warned.
"Our country is facing a period with high risks for food safety," Sun
Xianze, a senior official with the State Food and Drug Administration
(SFDA), said.
Sun, director of the department of food safety coordination under the
SFDA, made the warning at a seminar on food and drug supervision, held
over the weekend.
He said authorities faced an "arduous task" ahead.
A series of Chinese food exports ranging from pet food to seafood were
alleged to contain hazardous chemicals, sparkling wide concerns over the
country's food and drug safety.
"The food security problems have impeded Chinese agri-products and food
many times in international trade, and damaged our national credibility
and image," Sun said.
To ensure better quality of food and drug products, the SFDA has stepped
up efforts to push unqualified producers out of the market.
In a statement posted on its website, the SFDA said it had revoked the
production licenses of five drug manufacturers since last July and also
withdrawn the Good Manufacturing Practice (GMP) certificates from 128
drug makers mainly in Jilin, Henan, Hainan, Sichuan and Anhui provinces.
Eleven people were reported to have died last year taking a drug made by
the Qiqihar No 2 Pharmaceutical Co Ltd, in Northeast China's Heilongjiang
Province, one of the five companies shut down by the SFDA.
Guangdong Baiyi Pharmaceutical was reported to have made hemoglobin,
which was infected with a virus carried by a donor.
The administration also revoked the production licenses of three
factories in Fujian, Henan and Hebei provinces.
The SFDA said it had increased the number of GMP inspectors in
pharmaceutical factories and monitored the production quality of narcotic
drug makers across the country during the first half of this year.
In another development, the food and drug watchdog has suspended a drug
used to treat acute leukemia and rheumatoid arthritis after several
adverse reaction cases were found.
Several child patients suffering leukemia in three hospitals in the
Guangxi Zhuang Autonomous Region and Shanghai felt pain in their legs and
even had difficulty walking after being injected with the methotrexate, a
drug produced by Shanghai Hualian Pharmaceutical Co Ltd, according to the
SFDA.
The SFDA has ordered the local food and drug administrations in Guangxi
and Shanghai to reevaluate the drugs.
(China Daily 07/09/2007 page 3)
Vocabulary:
agri-productsũƷ
Good Manufacturing Practice淶
leukemiaѪ
rheumatoid arthritisʪԹؽ
Questions:
1. Why was Guangdong's Baihi Pharmaceutical plant's license revoked?
2. What are the 7 provinces listed in the article that have come under
the SFDA's radar?
3. What are the symptoms several child patients suffering from leukemia
suffered after taking methotrexate?
Answers:
1. They made a hemoglobin that was infected with a virus carried by a
donor.
2. Jilin, Henan, Hainan, Sichuan, Anhui, Fujian, and Hebui.
3. They felt pains in their legs and even had difficulty walking after
their injection.
Ӣ Linda ༭
About the broadcaster:
Suzann Riddle is a senior double majoring in Health Care Management and
Economics at Appalachian State University in Boone, NC. She finds herself
at China Daily Website after visiting many areas of China as a Holland
Fellow, Appalachian's international exchange program with Fudan
University.
Related Stories
ӢҰжࡰ 衱ô˵
Don't cry JoniͶ壩 Sex and the CityС֮
48Сʱ
ƵƼ
Seeing pressures and possibilities in urban growth
New 7 Wonders of the World announced
ԡټOur Farewell
С֮
Heat may be nature's deadliest killer
̳
ΪӢӦʲô
Six Simple Strategies to Beat the Heat(e-c)practice
˵ijǸʵˡ
̧ӡô˵أ
ٵη
one article ,one day
20071124 http://www.hellomandarin.net
No comments:
Post a Comment